Author (year) | Study design | Population (N) | Number of EC cases (N) | Follow-up time in years, mean*/median† (range) | Incidence (%) |
Bhattacharya et al 201122 | Retrospective cohort study | 11 299 | 2 | 6.2† (2.7–10.8) | 0.02 |
Cooper et al 200523 | Randomized controlled trial | 263 | 1 | NA (5.2–7) | 0.38 |
Dood et al 201413 | Retrospective cohort study | 4776 | 3 | 5.5† (IQR 3.2–8) | 0.06 |
Gaia et al 200724 | Retrospective cohort study | 3769 | 1 | NA (0–11) | 0.03 |
Kalampokas et al 201814 | Retrospective observational study | 901 | 2 | NA18–25 | 0.22 |
Krogh et al 200925 | Retrospective cohort study | 367 | 3 | 11.1* (8.1–14.6) | 0.82 |
Morelli et al 201515 | Retrospective observational study | 63 | 1 | NA (0–14) | 1.59 |
Neuwirth et al 20043 | Retrospective cohort study | 466 | 2 | NA6–24 | 0.43 |
Panoskaltsis et al 200226 | Prospective observational study | 193 | 0 | 6† (IQR 4–7) | 0.0 |
Singh et al 201616 | Retrospective observational study | 1521 | 0 | 10†2–17 | 0.0 |
Soini et al 201727 | Retrospective cohort study | 5484 | 3 | 7.3* (0–18) | 0.05 |
*Mean follow-up.
†Median follow-up.
EC, endometrial carcinoma; IQR, interquartile range.